Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus
Table 1
Examples of vancomycin interpretive criteria used internationally
| Interpretive criteria for vancomycin (µg/mL) | |||
|---|---|---|---|
| Organizationa |
Susceptible |
Intermediate |
Resistant |
| NCCLS | <4 | 8-16 | >32 |
| CA-SFM | <4 | 8-16 | >32 |
| BSAC | <4 | ------ | >8 |
aNCCLS, National Committee for Clinical Laboratory Standards; CA-SFM, Comité de l'Antibiogramme de la Société Française Microbiologie; BSAC, British Society for Antimicrobial Chemotherapy.
Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.